The Token Generation Event (TGE) market has turned into a high-risk zone. My analysis of data from 113 projects with an initial market cap of $100 million or more, launched since 2024, paints a grim picture: only 7.1% of tokens (8 out of 113) are currently trading above their offering price. The remaining 105 projects are in the red, with a median return across the entire sample of -95.7%. This means the typical token has lost 95.7% of its value since launch.
Winners and Losers: The Gap is Enormous
The list of profitable projects is led by Hyperliquid with its HYPE token, which has surged 1519% from its offering price. This is an absolute outlier, an order of magnitude ahead of the other leaders. Other profitable projects look much more modest: Ondo Finance (ONDO) showed +101.4%, EverValue Coin (EVA) +20.32%, and Midnight Network (NIGHT) +16.5%. The gap between the leader and the rest speaks for itself: even within this tiny group of winners, almost all the profit went to a single project.
Why Are New Tokens Almost Always Unprofitable?
The statistics reveal a systemic market problem. New tokens hit exchanges with inflated valuations set by venture capital funds during private rounds. Retail buyers face a price with virtually no room for growth. Then the unlock schedule comes into play: teams and early investors receive their tokens gradually and sell them over months, creating constant downward pressure on the price. The liquidity of new projects exacerbates the situation: trading is concentrated in the first weeks after launch, then interest fades, volumes dry up, and even small sell-offs can crash prices by tens of percent.
My expert opinion: Buying a token at launch remains one of the riskiest bets in the crypto industry. Rare success stories like Hyperliquid are exceptions that only prove the rule: 92.9% of projects result in losses for investors. Participating in a TGE today is not an investment, but a lottery with extremely low odds of winning. The only way to reduce risks is to thoroughly analyze the tokenomics, unlock schedule, and real metrics of the project, rather than chasing hype.